|
|
|
Specialty:
|
|
Oncology/Medicine
Hematology/Oncology
Cancer
Blood Disorders
|
|
Areas of Interest:
|
|
Melanoma
General Oncology
Hematology
|
|
Certification:
|
|
American Board of Internal Medicine
American Board of Internal Medicine/Hematology
American Board of Internal Medicine/Medical Oncology
|
|
MetroHealth Appointment:
|
|
1992
|
|
|
| Location | Division | Appointment |
| MetroHealth Medical Center | Hematology/Oncology | 216-778-5802 |
|
|
|
|
|
|
|
|
|
|
|
|
Medical School:
|
|
Case Western Reserve University, Cleveland, Ohio
|
|
Internship:
|
|
Strong Memorial Hospital, Rochester, New York
|
|
Residency:
|
|
Strong Memorial Hospital, Rochester, New York
University Hospitals of Cleveland, Cleveland, Ohio
|
|
Fellowship:
|
|
University Hospitals of Cleveland, Cleveland, Ohio
|
|
|
|
|
|
Selected Publications:
|
|
Clark JW, Smith JW II, Steis RG, Urba WJ, Crum ED, et al: Interleukin-2 and
lymphokine activated killer cells: analysis of a bolus interleukin-2 and a continuous interleukin-2 infusion regimen. Cancer Res 50:7343-7350, 1990.
Crum ED, Kaplan DR: In vivo activity of solid phase interleukin 2. Cancer Res
51:875-879, 1991.
Crum ED: Effect of cisplatin upon expression of in vivo immune tumor resistance.
Cancer Immunol Immunother, 36:18-25,1993.
Winter JN, Mangan C, Bryd K, Tallman M, Gordon L. Jahnke L, Lazarus H, Cooper B, Crum E, Horvath N. et al: Combined therapy with rG-CSF and GM-CSF for the mobilization of hematopoietic progenitor cells. Progress in Clinical & Biological Research 389:463-470, 1994.
O'Brien, T., and Crum, E. Atypical presentations of thrombotic thrombocytopenic purpura. International Journal of Hematology. 2002; 76: 471-473.
|
|